Fosun International H1 2026 Revenue Hits RMB 86.96 Billion, Net Profit Surges 160.3%
Fosun International reported 2026 interim results on August 27, with total revenue of RMB 86.96 billion and industrial operating profit of RMB 3.69 billion, up 17% year-on-year. Net profit attributable to shareholders reached RMB 1.72 billion, a 160.3% increase. Overseas revenue rose 5.3% to RMB 49.16 billion, accounting for 56.5% of total revenue.
Fosun International announced its 2026 interim results on the evening of August 27. During the reporting period, the group's total revenue reached RMB 86.96 billion, while industrial operating profit amounted to RMB 3.69 billion, up 17% year-on-year. Net profit attributable to shareholders of the parent company stood at RMB 1.72 billion, representing a 160.3% increase. On August 27, Fosun International's share price was HKD 5.415, giving a market capitalization of HKD 44.01 billion.
By segment, the combined revenue of Fosun Pharma, Yuyuan Inc. , Fosun Portugal Insurance, and the Fosun Tourism division reached RMB 63.88 billion, accounting for 73.5% of the group's total revenue. Overseas revenue grew 5.3% year-on-year to RMB 49.16 billion, with its share of total revenue rising by 3 percentage points from the same period in 2025 to 56.5%.